Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • US

Tag: US

  • BiotechToday
  • World

Priority Review for Pfizer’s tick-borne encephalitis vaccine in the US

bioxone March 4, 2021March 4, 2021 1

Devyani Goswami, Amity University Kolkata Nanette Cocero, global president, vaccines, of Pfizer announced that their tick-borne encephalitis vaccine (TBE) has been approved for a priority review from the US Food and Drug Administration (FDA).  Once approved the vaccine promises to cure tick-borne encephalitis epidemics all across the US. The vaccine has to be subjected twice […]

Read More
  • BiotechToday
  • World

How much plastic are you eating? New study revealed

bioxone January 2, 2021January 2, 2021 1

Sampriti Roy, University of Calcutta The fractions of plastic debris that are less than 5 mm in the largest dimension or diameter are commonly referred to as microplastics. Microscopic plastic debris mainly results from the fragmentation of larger plastic debris that enters rivers and eventually reaches the oceans.  Recent literature indicates that microplastic debris is […]

Read More
  • BiotechToday
  • World

Plant-based Meat Production

bioxone December 11, 2020December 11, 2020

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Animal-based meat production has grown over the years to meet the demand for cost-effective and appetizing food. However, this treat is accompanied by unnoticed consequences for human health, the environment, and the animals involved. Focusing on the rise in global meat demand, researchers, and entrepreneurs are focusing on plant-based approaches […]

Read More
  • BiotechToday
  • World

FGFR1-targeted kinase inhibitors can now help in treating breast cancer

bioxone November 2, 2020November 2, 2020 1

Camelia Bhattacharyya, Amity University Kolkata Breast cancer, a term which scares most women, a type of cancer which changes the life of a patient even those who are survivors, is a much-studied and researched topic around the globe. The early symptoms might include the appearance of a lump at any portion of the breast, blood […]

Read More
  • BiotechToday
  • World

EFFECT OF MISSENSE VARIATIONs: REVELEALED

bioxone November 1, 2020November 1, 2020 2

DEEPON CHAKRABORTY, UNIVERSITY OF CALCUTTA Interpretation of a large number of genetic variants identified from sequencing is one of the breakthroughs of clinical genetics. It is also termed as genetic screening. The main challenge is the identification of the effect of amino acid substituting missense variation on protein structure and function. Its several applications are […]

Read More
  • BiotechToday
  • World

Newly discovered salivary glands aid advanced radiation therapies

bioxone October 23, 2020October 23, 2020

Jayateerth S. Bhavikatti, CSIR-National Chemical Laboratory, Pune, India There have been so many things discovered till date in this universe, nevertheless, there are too many discoveries to happen. Cheers to the discoverers! They spend their life helping people. Here is one such discovery. So far, three pairs of salivary glands were studied in humans. Researches […]

Read More
  • BiotechToday
  • India

Synthesis of Bio-Oil from waste as an alternative for conventional fuel

bioxone October 22, 2020October 21, 2020

Srilagna Sarkar, Amity University Kolkata Researchers from various sectors have started shifting to renewable energy resources from conventional fossil fuels due to their high consumption percentage. As we know the bio-origin materials are capable of producing a variety of energy resources like Biofuels through many conversion routes like bio & thermochemical and also direct combustion […]

Read More
  • BiotechToday
  • World

Fetus in Fetu analysis by modern Multimode Ultrasound

bioxone October 22, 2020October 21, 2020

Souradip Mallick, National Institute of Technology, Rourkela Fetus in fetu (FIF) has been defined as the presence of one of the twins in the body of the other. It is a condition in which malformed and parasitic fetus is located in the body of the normal fetus. It is very difficult for the radiologist to […]

Read More
  • BiotechToday
  • World

Identifying Host Factors to Inhibit Entry of SARS-Cov-2 And Ebola Virus

bioxone October 14, 2020October 14, 2020

Sampriti Roy, Asutosh College (University of Calcutta) When speaking of cell mechanisms, there are still a large number of the same that remain largely unknown. From understanding viral pathogenesis to antiviral therapeutics development – the identification of viral mechanisms and understanding how the virus defends itself is crucial. This is the case particularly for those […]

Read More
  • BiotechToday
  • India
  • World

AstraZeneca: Late-stage trial of Covid-19 antibody medicine to start soon

bioxone October 12, 2020October 12, 2020

Prama Ghosh, Amity University Kolkata After the recovery of President Donald Trump from Covid-19 using a similar therapy as of the antibody medicine from AstraZeneca Plc, the company has started its late-stage trials for the same against COVID-19. The medicine will undergo two trials on more than 60000 people starting soon. Astra has also planned […]

Read More

Posts navigation

1 2 3

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy